Holobiome and Radicle Science announced a two-year trial testing 19 prebiotics for anxiety. Learn why experts advise waiting for the 2027 results.
On October 8, 2026, Holobiome and Radicle Science announced the launch of a two-year research initiative to test 19 prebiotic formulations in more than 6,000 Americans experiencing anxiety.
Before this new trial announcement, the scientific community held a cautious view regarding prebiotics and mental wellness. Researchers have investigated how dietary changes influence digestion and mood for years. However, clinical understanding of the gut-brain connection remains preliminary. Experts view the potential of neuropsychiatric applications as promising but recognize that finding definitive proof requires massive clinical efforts. Until now, producing large-scale multimodal data from interventional trials has been a missing link in translating gut-microbiome research into everyday products.
Prebiotics are essentially specialized plant fibers that the human body cannot digest on its own. Instead of breaking down in the stomach, they travel to the lower digestive tract. Once there, they serve as a primary food source for beneficial gut bacteria. When these bacteria consume the fibers, they produce various compounds that communicate with the rest of the body. You can learn more about how everyday habits affect your body by reading our resources on gut microbiome and digestive science.
Historically, the inconsistency in previous study results stems from numerous biological variables. Individual responses to dietary fibers vary significantly. A person's baseline digestion plays a major role in how their body reacts to new prebiotic additions. General gastrointestinal tolerance also influences these outcomes. Because everyone has a unique internal system, a single formulation rarely produces the identical result for every individual.
Finding clear, actionable benefits has historically required larger studies that combine behavioral assessments with deep biological tracking. Small sample sizes often fail to capture the complex relationship between the digestive system and the brain. Without massive data sets, it is difficult to determine whether food-based approaches can meaningfully improve mental wellness across a diverse population. This historical lack of objective, large-scale data has left consumers with conflicting advice regarding gut health and stress.
The new GUT-FEELINGS initiative represents a major shift toward generating massive amounts of multimodal data from a single interventional trial. According to the announcement, Holobiome and Radicle Science are conducting this two-year research project with support from the U.S. Advanced Research Projects Agency for Health. This agency is widely known as ARPA-H. The study is officially part of ARPA-H's EVIDENT initiative, which focuses entirely on finding objective measures of mental health and well-being. By measuring physical changes alongside psychological ones, researchers hope to map the gut-brain connection more clearly.
The gut-brain connection operates as a two-way communication system between the digestive tract and the central nervous system. This network involves chemical signals, hormones, and direct nerve pathways. Researchers believe that the compounds produced by gut bacteria during digestion can influence these communication channels. If scientists can understand exactly how specific fibers alter these signals, they might uncover new ways to support overall mental wellbeing.
The trial features a 16-week randomized design with 20 distinct study arms. The companies plan to test 19 proprietary, food-derived prebiotic formulations against a placebo group. The study will enroll more than 6,000 Americans experiencing feelings of anxiety, rolling out the participant groups in two separate waves. This massive scale aims to address the exact limitations of previous small-scale microbiome studies.
Researchers plan to assess multiple validated measures of mental wellness. These measures include anxiety, stress, mood, and sleep. The study will also track physical metrics such as weight, waist measurements, and diet quality. To monitor biological changes, the initiative will collect more than 24,000 fecal samples and 12,000 blood samples from the participants.
The biological data collection extends beyond standard clinical samples. The tracking includes microbiome sequencing, metabolomics, and blood proteomics. Researchers will also use wearable tracking devices and continuous glucose monitoring to gather digital data. Holobiome CEO and co-founder Philip Strandwitz noted that generating large-scale multimodal data from an interventional trial is a necessary step for the industry. Radicle Science co-founders Pelin Thorogood and Jeff Chen added that the project aims to use human evidence earlier in product development, rather than only to validate products after they are made.
While the GUT-FEELINGS study is ambitious, the announcement lacks crucial protocol details. The 19 prebiotic formulations are described as proprietary, and the companies have not disclosed their specific ingredients or doses. Without knowing what the formulations contain, readers cannot compare these interventions to standard dietary fibers. We encourage readers to understand the basics of probiotics, prebiotics, and gut supplements before attempting targeted dietary changes.
The announcement also leaves several aspects of the participant population undefined. The target group includes individuals experiencing feelings of anxiety. However, this phrasing does not establish a requirement for a formal clinical anxiety diagnosis. Furthermore, the companies do not state the amount of ARPA-H funding awarded for the project. The announcement also lacks information on how the thousands of participants will be allocated across the 20 different study arms.
These missing details make it difficult to assess the trial's underlying statistical power. The companies refer to the project as the largest mental wellness trial in U.S. history. This framing is a company-announcement claim, and the provided materials offer no independent comparative evidence to establish that superlative. Additionally, Jonathan E. Fielding, a UCLA distinguished professor and former Los Angeles County public health director, noted the trial could help establish if food-based approaches improve wellness. However, these are expectations attributed to quoted individuals, not independent evaluations of the study's prospective impact.
It is critical to remember that this event is merely a study launch. The announcement reports no results or evidence that any of the 19 prebiotic formulations are currently effective. Initial results from the trial are not expected until the second half of 2027. The project also exists within a commercial wellness-trial market, which explains its commercial relevance but does not independently validate its design or future results.
Consumers should treat this announcement strictly as news about an upcoming study. The launch of a clinical trial is not a recommendation to buy a prebiotic supplement. It also does not prove that any current product will relieve anxiety. Because the specific ingredients and doses remain undisclosed, you cannot use this information to select a comparable product for your own routine. The safest approach is to focus on digestion and everyday gut function through a varied, nutrient-dense diet.
For individuals interested in the gut-brain connection, the useful development will be the eventual publication of the results in 2027. It will be valuable to observe whether the study successfully reports both mental-wellness outcomes and objective biological measures. The trial's stated goals include identifying which interventions might work for specific populations. This goal aligns with the established understanding that digestive health is highly individualized.
Current mental-health findings related to prebiotics remain largely exploratory. This variation argues against the idea that one single formulation will suit everyone experiencing stress or digestive discomfort. Waiting for objective, peer-reviewed data is always the best strategy when evaluating targeted dietary changes.
Assuming that the announcement of a large clinical trial guarantees immediate product effectiveness often leads consumers to adopt unproven dietary changes. Many individuals experience uncertainty about probiotics, prebiotics, fermented foods and gut supplements. DigestGenius prevents this confusion by maintaining our Educational Content Platform (flagship), which provides free educational articles and in-depth resources about digestion, microbiome science, nutrition and digestive wellness.
DigestGenius publishes research-led guidance on digestion, the gut microbiome, fiber, probiotics, gut-brain signaling, inflammation and everyday digestive wellbeing.
Explore clear, research-led guidance on digestion, the microbiome, food, fiber, probiotics and the gut-brain connection.
read the blog
